{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:49:22Z","timestamp":1790707762403,"version":"4.1.0"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T00:00:00Z","timestamp":1486080000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25462220"],"award-info":[{"award-number":["25462220"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25293310"],"award-info":[{"award-number":["25293310"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["15K19974"],"award-info":[{"award-number":["15K19974"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["26860567"],"award-info":[{"award-number":["26860567"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0171515","type":"journal-article","created":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T13:41:07Z","timestamp":1486129267000},"page":"e0171515","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":88,"title":["Administration of bovine casein-derived peptide prevents cognitive decline in Alzheimer disease model mice"],"prefix":"10.1371","volume":"12","author":[{"given":"Li-Juan","family":"Min","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yodai","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0275-9198","authenticated-orcid":true,"given":"Masaki","family":"Mogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kana","family":"Tsukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiaki","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Iwanami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Zhong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatsugu","family":"Horiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,2,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","article-title":"Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein","volume":"120","author":"GG Glenner","year":"1984","journal-title":"Biochem Biophys Res Commun"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000237873","article-title":"Inflammation and anti-inflammatory strategies for Alzheimer's disease\u2014a mini-review","volume":"56","author":"BB McNaull","year":"2010","journal-title":"Gerontology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/382120b0","article-title":"Oxidative damage in Alzheimer's","volume":"382","author":"MA Smith","year":"1996","journal-title":"Nature"},{"key":"ref4","first-page":"1005","article-title":"Inflammation in Alzheimer disease: driving force, bystander or beneficial response?","volume":"12","author":"T Wyss-Coray","year":"2006","journal-title":"Nat Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/sj.jhh.1001065","article-title":"Antihypertensive effect of valyl-tyrosine, a short chain peptide derived from sardine muscle hydrolyzate, on mild hypertensive subjects","volume":"14","author":"T Kawasaki","year":"2000","journal-title":"J Hum Hypertens"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1248\/bpb.27.189","article-title":"Antihypertensive effect of peptides from royal jelly in spontaneously hypertensive rats","volume":"27","author":"KH Tokunaga","year":"2004","journal-title":"Biol Pharm Bull"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2174\/138161207780363068","article-title":"Angiotensin converting enzyme inhibitory peptides derived from food proteins: biochemistry, bioactivity and production","volume":"13","author":"BA Murray","year":"2007","journal-title":"Curr Pharm Des"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.foodchem.2014.09.098","article-title":"Antihypertensive effect of the bovine casein-derived peptide Met-Lys-Pro","volume":"172","author":"A Yamada","year":"2015","journal-title":"Food Chem"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1016\/j.foodchem.2013.06.089","article-title":"Novel angiotensin I-converting enzyme inhibitory peptide derived from bovine casein","volume":"141","author":"A Yamada","year":"2013","journal-title":"Food Chem"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S1474-4422(07)70077-7","article-title":"Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease?","volume":"6","author":"PG Kehoe","year":"2007","journal-title":"Lancet Neurol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"169649","DOI":"10.1155\/2012\/169649","article-title":"Roles of brain angiotensin II in cognitive function and dementia","volume":"2012","author":"M Mogi","year":"2012","journal-title":"Int J Hypertens"},{"key":"ref12","first-page":"163","article-title":"Angiotensin-converting enzyme levels and activity in Alzheimer's disease: differences in brain and CSF ACE and association with ACE1 genotypes","volume":"1","author":"S Miners","year":"2009","journal-title":"Am J Transl Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1089\/ars.2012.4641","article-title":"Angiotensin II, NADPH oxidase, and redox signaling in the vasculature","volume":"19","author":"A Nguyen Dinh Cat","year":"2013","journal-title":"Antioxid Redox Signal"},{"key":"ref14","first-page":"171","article-title":"Brain renin-angiotensin system in cognitive function: pre-clinical findings and implications for prevention and treatment of dementia","volume":"109","author":"A Ciobica","year":"2009","journal-title":"Acta Neurol Belg"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1096\/fj.11-182873","article-title":"Perindopril, a centrally active angiotensin-converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease","volume":"25","author":"YF Dong","year":"2011","journal-title":"FASEB J"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1532-5415.2004.52178_7.x","article-title":"Angiotensin-converting enzyme inhibitors and incidence of Alzheimer's disease in Japan","volume":"52","author":"T Ohrui","year":"2004","journal-title":"J Am Geriatr Soc"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.nbd.2014.04.018","article-title":"Angiotensin II type 1 receptor blocker losartan prevents and rescues cerebrovascular, neuropathological and cognitive deficits in an Alzheimer's disease model","volume":"68","author":"B Ongali","year":"2014","journal-title":"Neurobiol Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1001\/archinternmed.2009.175","article-title":"Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study","volume":"169","author":"KM Sink","year":"2009","journal-title":"Arch Intern Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/HYPERTENSIONAHA.109.136879","article-title":"Cognitive deficit in amyloid-beta-injected mice was improved by pretreatment with a low dose of telmisartan partly because of peroxisome proliferator-activated receptor-gamma activation","volume":"54","author":"K Tsukuda","year":"2009","journal-title":"Hypertension"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.brainres.2009.08.068","article-title":"Sex-different effect of angiotensin II type 2 receptor on ischemic brain injury and cognitive function","volume":"1300","author":"A Sakata","year":"2009","journal-title":"Brain Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1161\/HYPERTENSIONAHA.107.101634","article-title":"Diabetes-associated cognitive impairment is improved by a calcium channel blocker, nifedipine","volume":"51","author":"K Tsukuda","year":"2008","journal-title":"Hypertension"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1161\/HYPERTENSIONAHA.107.105577","article-title":"High-normal blood pressure is associated with poor cognitive performance","volume":"51","author":"S Knecht","year":"2008","journal-title":"Hypertension"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/ajh.2009.212","article-title":"Hypertension and dementia","volume":"23","author":"M Nagai","year":"2010","journal-title":"Am J Hypertens"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1161\/HYPERTENSIONAHA.110.163055","article-title":"Midlife and late-life blood pressure and dementia in Japanese elderly: the Hisayama study","volume":"58","author":"T Ninomiya","year":"2011","journal-title":"Hypertension"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1161\/STR.0b013e3182299496","article-title":"Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"42","author":"PB Gorelick","year":"2011","journal-title":"Stroke"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S1474-4422(11)70072-2","article-title":"The projected effect of risk factor reduction on Alzheimer's disease prevalence","volume":"10","author":"DE Barnes","year":"2011","journal-title":"Lancet Neurol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1097\/00004872-200306005-00003","article-title":"Perindopril pROtection aGainst REcurrent Stroke Study (PROGRESS): interpretation and implementation","volume":"21","author":"J Chalmers","year":"2003","journal-title":"J Hypertens Suppl"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(01)06178-5","article-title":"Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack","volume":"358","year":"2001","journal-title":"Lancet"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.brainres.2010.07.006","article-title":"Effect of a centrally active angiotensin-converting enzyme inhibitor, perindopril, on cognitive performance in a mouse model of Alzheimer's disease","volume":"1352","author":"K Yamada","year":"2010","journal-title":"Brain Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2967\/jnumed.112.109751","article-title":"Quantitative evaluation of cerebral blood flow and oxygen metabolism in normal anesthetized rats: 15O-labeled gas inhalation PET with MRI Fusion","volume":"54","author":"T Watabe","year":"2013","journal-title":"J Nucl Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.brainres.2009.05.035","article-title":"Validation of Abeta1-40 administration into mouse cerebroventricles as an animal model for Alzheimer disease","volume":"1280","author":"S Takeda","year":"2009","journal-title":"Brain Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/j.1476-5381.2011.01299.x","article-title":"Animal models in the drug discovery pipeline for Alzheimer's disease","volume":"164","author":"D Van Dam","year":"2011","journal-title":"Br J Pharmacol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s12272-010-1006-7","article-title":"Inflammation and Alzheimer's disease","volume":"33","author":"YJ Lee","year":"2010","journal-title":"Arch Pharm Res"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1523\/JNEUROSCI.21-12-04183.2001","article-title":"Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis","volume":"21","author":"D Pratico","year":"2001","journal-title":"J Neurosci"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0531-5565(01)00191-7","article-title":"Proinflammatory cytokines in sera of elderly patients with dementia: levels in vascular injury are higher than those of mild-moderate Alzheimer's disease patients","volume":"37","author":"R Paganelli","year":"2002","journal-title":"Exp Gerontol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.bbr.2007.12.014","article-title":"Restraining tumor necrosis factor-alpha by thalidomide prevents the amyloid beta-induced impairment of recognition memory in mice","volume":"189","author":"T Alkam","year":"2008","journal-title":"Behav Brain Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1006\/bbrc.2000.2897","article-title":"Activation of NADPH oxidase in Alzheimer's disease brains","volume":"273","author":"S Shimohama","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0006-8993(89)90095-4","article-title":"Angiotensin II inhibits the release of [3H]acetylcholine from rat entorhinal cortex in vitro","volume":"491","author":"JM Barnes","year":"1989","journal-title":"Brain Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0006-8993(90)90294-L","article-title":"Angiotensin II inhibits acetylcholine release from human temporal cortex: implications for cognition","volume":"507","author":"JM Barnes","year":"1990","journal-title":"Brain Res"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.nbd.2014.04.018","article-title":"Angiotensin II type 1 receptor blocker losartan prevents and rescues cerebrovascular, neuropathological and cognitive deficits in an Alzheimer's disease model","volume":"68","author":"B Ongali","year":"2014","journal-title":"Neurobiol Dis"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0171515","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T03:15:10Z","timestamp":1568776510000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0171515"}},"subtitle":[],"editor":[{"given":"M\u00e1ria A.","family":"Deli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,2,3]]},"references-count":40,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,2,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0171515","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,3]]}}}